Oramed Pharmaceuticals (ORMP) Minority Interest (2021 - 2025)
Oramed Pharmaceuticals' (ORMP) quarterly Minority Interest came in at -$952000.0 in Q3 2025, down 3.59% YoY from -$987458.2 in Q3 2024, and down 0.63% on a QoQ basis from -$946000.0 in Q2 2025.
Oramed Pharmaceuticals (ORMP) Minority Interest (2021 - 2025) Analysis & Trends
Oramed Pharmaceuticals (ORMP) has 5 years of Minority Interest data on file, last reported at -$952000.0 in Q3 2025.
- Quarterly Minority Interest fell 3.59% year-over-year to -$952000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$952000.0 (down 3.59% YoY) and the FY2024 annual result came in at -$918000.0, up 1.08% from the prior year.
- Minority Interest retreated to -$952000.0 in Q3 2025, from -$946000.0 in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $1.1 million in Q2 2021 to a low of -$952000.0 in Q3 2025.
- A 5-year average of -$542833.3 and a median of -$896500.0 in 2023 frame the typical range for Minority Interest.
- Annual changes were most pronounced in 2023 — Minority Interest slumped 552.38% — and 2024, when it increased 1.08%.
- Tracing ORMP's Minority Interest over 5 years: stood at $536000.0 in 2021, then tumbled by 222.39% to -$656000.0 in 2022, then sank by 41.46% to -$928000.0 in 2023, then climbed by 1.08% to -$918000.0 in 2024, then declined by 3.7% to -$952000.0 in 2025.
- The last three Minority Interest figures came in at -$952000.0 (Q3 2025), -$946000.0 (Q2 2025), and -$918000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Oramed Pharmaceuticals | 197.61 Mn | 197.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -952,000.00 |
| Jun 30, 2025 | -946,000.00 |
| Mar 31, 2025 | -918,000.00 |
| Dec 31, 2024 | -918,000.00 |
| Sep 30, 2024 | -919,000.00 |
| Jun 30, 2024 | -911,000.00 |
| Mar 31, 2024 | -918,000.00 |
| Dec 31, 2023 | -928,000.00 |
| Sep 30, 2023 | -902,000.00 |
| Jun 30, 2023 | -891,000.00 |
| Mar 31, 2023 | -822,000.00 |
| Dec 31, 2022 | -656,000.00 |
| Sep 30, 2022 | -661,000.00 |
| Jun 30, 2022 | -660,000.00 |
| Mar 31, 2022 | -126,000.00 |
| Nov 30, 2021 | 536,000.00 |
| Aug 31, 2021 | 744,000.00 |
| May 31, 2021 | 1.08 Mn |